Novo Nordisk's CEO said the complexities of the U.S. healtchare system prevented access to $1,349 Wegovy.
During a recent subcommittee hearing, Sanders called out Novo Nordisk’s CEO and demanded that Americans be treated fairly. "All we are saying, Mr. Jørgensen, is treat the American people the same way ...
The CEO of Novo Nordisk is on Capitol Hill Tuesday to testify before a Senate committee about the high costs of its drugs ...
When Nvidia (NVDA) reported $30 billion in revenue in its second-quarter earnings results, the AI chipmaker disclosed that ...
Ozempic is a popular diabetes drug that is also used for weight loss by suppressing appetite. Sanders expressed confidence ...
The health benefits of blockbuster weight loss drugs are bridging the stark political divide in the United States.
Ozempic and Wegovy are making so much money for Novo Nordisk A/S that their cumulative sales will soon surpass the ...